UNC1666
UNC1666 is an ATP-competitive dual-target Mer/Flt3 tyrosine kinase inhibitor with IC50 values of 0.55 nM and 0.69 nM, and Ki values of 0.16 nM and 0.67 nM, respectively. UNC1666 reduces the phosphorylation levels of Mer and Flt3, suppresses downstream pro-survival signaling pathways (Erk1/2, Akt and Stat), induces cell apoptosis, and decreases colony formation of acute myeloid leukemia cells. UNC1666 is applicable to research related to acute myeloid leukemia.
For research use only. We do not sell to patients.
- CAS No.: 1429882-12-1
- Formula: C26H35N5O4S
- Molecular Weight:513.66
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
UNC1666 (Analogue 2) exhibits subnanomolar to low nanomolar in vitro inhibitory activity against Mer, Flt3, Axl (29 nM) and Tyro3 (37 nM) kinases, with the most potent activity against Flt3 (0.69 nM) and Mer (0.93 nM)[1].
UNC1666 (10-300 nM) inhibits Mer phosphorylation in Kasumi-1 AML cells in a concentration-dependent manner, and potently suppresses Flt3 phosphorylation in MV4;11 Flt3-ITD AML cells[2].
UNC1666 (50-300 nM) dose-dependently inhibits the downstream pro-survival signaling pathways (Erk1/2, Akt, and Stat) in Mer-positive Kasumi-1 cells and Flt3-ITD MV4;11 AML cells following 2 h of treatment, with stronger activity observed in Flt3-ITD cells[2].
UNC1666 (10-300 nM; 72 h) induces apoptosis in Mer-positive and Flt3-ITD AML cell lines in a dose-dependent manner after 72 hours of treatment[2].
UNC1666 (50-300 nM; 72 h) inhibits the long-term rebound growth of Kasumi-1 and MV4;11 acute myeloid leukemia (AML) cells even after the completion of treatment[2].
UNC1666 (10-300 nM; 72 h) significantly reduces the colony-forming ability of Mer-positive and Flt3-ITD AML cell lines cultured in soft agar[2].
UNC1666 (50-300 nM; 2 h) dose-dependently inhibits the phosphorylation of Mer and Flt3 in primary AML blasts co-expressing Mer and Flt3ITD, suppresses downstream pro-survival signaling pathways (Erk1/2, Akt, Stat5) in the cells, induces cellular apoptosis, and reduces colony-forming ability[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Mer-positive (Kasumi-1, NOMO-1) and Flt3-ITD (MV4;11, MOLM-13) AML cell lines
-
Concentration:10, 25, 50, 100, 300nM
-
Incubation Time:72 h
-
Result:Induced apoptosis in 50-67% of Mer-positive cells at 100 nM, and 68-76% of Mer-positive cells at 300 nM, with Kasumi-1 cells showing 76% apoptotic/dead cells at 300 nM.
Induced apoptosis in 54-67% of Flt3-ITD cells at 50 nM, and 90-98% of Flt3-ITD cells at 300 nM, with MV4;11 cells showing 90% apoptotic/dead cells at 300 nM and MOLM-13 cells showing 98% apoptotic/dead cells at 300 nM.
Confirmed increased cleavage of PARP and Caspase-3 in a dose-dependent manner via immunoblot.
-
Cell Line:Mer-positive (Kasumi-1) and Flt3-ITD (MV4;11) AML cell lines
-
Concentration:50, 100, 300nM
-
Incubation Time:72 h (initial treatment)
-
Result:Resulted in only a 2.5-fold increase in viable cell number over 6 days in Kasumi-1 cells at 100 nM, compared to a 14-fold increase with vehicle.
Resulted in only a 13-fold increase in viable cell number over 6 days in MV4;11 cells at 50 nM, compared to a 67-fold increase with vehicle.
Caused more striking proliferation defects at higher concentrations, with minimal viable cells at Day 6.
-
Cell Line:Mer-positive (Kasumi-1, NOMO-1) and Flt3-ITD (MV4;11, MOLM-13) AML cell lines
-
Concentration:10, 25, 50, 100, 300nM
-
Incubation Time:Continuous treatment, medium renewed twice weekly (14-21 days total)
-
Result:Reduced Kasumi-1 cell colony formation by 90% at 100 nM.
Reduced NOMO-1 cell colony formation by 71% at 100 nM.
Reduced MV4;11 cell colony formation by 61% at 50 nM.
Reduced MOLM-13 cell colony formation by 93% at 50 nM.
Chemical Information
-
CAS No. 1429882-12-1
-
Molecular Weight 513.66
-
Formula C26H35N5O4S
-
SMILES
N(CCCC)C=1N=C2C(C(=CN2[C@H]3CC[C@H](O)CC3)C4=CC=C(S(=O)(=O)N5CCOCC5)C=C4)=CN1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
Purity & Documentation
References
[1]. Zhang W, et al. UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem. 2014;57(16):7031-7041. [Content Brief]
[2]. Lee-Sherick AB, et al. Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia. Oncotarget. 2015;6(9):6722-6736. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)